Radiosensitizing effect of withaferin A combined with hyperthermia on mouse fibrosarcoma and melanoma - PubMed (original) (raw)
Radiosensitizing effect of withaferin A combined with hyperthermia on mouse fibrosarcoma and melanoma
Pathirissery Uma Devi et al. J Radiat Res. 2003 Mar.
Free article
Abstract
The effect of withaferin A, a plant withanolide, alone or in combination with acute and fractionated radiotherapy and/or hyperthermia, was tested on two mouse tumors, B16F1 melanoma and fibrosarcoma, grown in C57BL and Swiss albino mice, respectively. Tumors were exposed locally to 30 or 50 Gy gamma radiation as acute dose, or 5 fractions of 10 Gy. Withaferin A, 40 mg/kg, was injected intraperitoneally, 1h before acute irradiation, or 30 mg/kg before every 10 Gy fraction. Local hyperthermia, 43 degrees C for 30 min, followed acute RT or first fraction of 10 Gy. Withaferin A, radiation and hyperthermia, individually and in bimodality treatments, produced no complete response (CR) in melanoma. Some CR were seen in fibrosarcoma, which increased after bimodality treatments. Trimodality treatment synergistically increased CR to 37% in melanoma and to 64% in fibrosarcoma. Fractionated radiotherapy (10 Gy x 5) was more effective (25% CR) than acute dose of 50 Gy (0% CR) on melanoma, while there was no difference between the response of fibrosarcoma to the two regimens. Withaferin A with fractionated radiotherapy synergistically increased the CR of both tumors; hyperthermia further enhanced this effect. Utility of withaferin A in increasing the clinical response of radioresistant tumors to fractionated radiotherapy has to be explored.
Similar articles
- Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia.
Kalthur G, Pathirissery UD. Kalthur G, et al. Integr Cancer Ther. 2010 Dec;9(4):370-7. doi: 10.1177/1534735410378664. Epub 2010 Aug 16. Integr Cancer Ther. 2010. PMID: 20713375 - Radiosensitization of a mouse melanoma by withaferin A: in vivo studies.
Devi PU, Kamath R, Rao BS. Devi PU, et al. Indian J Exp Biol. 2000 May;38(5):432-7. Indian J Exp Biol. 2000. PMID: 11272405 - Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo.
Sharada AC, Solomon FE, Devi PU, Udupa N, Srinivasan KK. Sharada AC, et al. Acta Oncol. 1996;35(1):95-100. doi: 10.3109/02841869609098486. Acta Oncol. 1996. PMID: 8619948 - In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma.
Devi PU, Sharada AC, Solomon FE. Devi PU, et al. Cancer Lett. 1995 Aug 16;95(1-2):189-93. doi: 10.1016/0304-3835(95)03892-z. Cancer Lett. 1995. PMID: 7656229 - An overview of the role of radiation therapy and hyperthermia in treatment of malignant melanoma.
Shidnia H, Hornback NB, Shen RN, Shupe RE, Yune M. Shidnia H, et al. Adv Exp Med Biol. 1990;267:531-45. doi: 10.1007/978-1-4684-5766-7_58. Adv Exp Med Biol. 1990. PMID: 2128438 Review.
Cited by
- Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC, Choi BY. Lee IC, et al. Int J Mol Sci. 2016 Mar 4;17(3):290. doi: 10.3390/ijms17030290. Int J Mol Sci. 2016. PMID: 26959007 Free PMC article. Review. - Withania somnifera: From prevention to treatment of cancer.
Palliyaguru DL, Singh SV, Kensler TW. Palliyaguru DL, et al. Mol Nutr Food Res. 2016 Jun;60(6):1342-53. doi: 10.1002/mnfr.201500756. Epub 2016 Jan 29. Mol Nutr Food Res. 2016. PMID: 26718910 Free PMC article. Review. - Withanolide D Enhances Radiosensitivity of Human Cancer Cells by Inhibiting DNA Damage Non-homologous End Joining Repair Pathway.
Lacombe J, Cretignier T, Meli L, Wijeratne EMK, Veuthey JL, Cuendet M, Gunatilaka AAL, Zenhausern F. Lacombe J, et al. Front Oncol. 2020 Jan 8;9:1468. doi: 10.3389/fonc.2019.01468. eCollection 2019. Front Oncol. 2020. PMID: 31970089 Free PMC article. - Withaferin A and its potential role in glioblastoma (GBM).
Dhami J, Chang E, Gambhir SS. Dhami J, et al. J Neurooncol. 2017 Jan;131(2):201-211. doi: 10.1007/s11060-016-2303-x. Epub 2016 Nov 11. J Neurooncol. 2017. PMID: 27837436 Review.